http://blog.pharmtech.com/2008/12/19/merck-and-biosimilars-sound-business-or-just-small-molecule-blues/ The blog of Pharmaceutical Technology magazine Tue, 07 Feb 2012 17:25:13 -0500 http://wordpress.org/?v=2.8.4 hourly 1 http://blog.pharmtech.com/2008/12/19/merck-and-biosimilars-sound-business-or-just-small-molecule-blues/comment-page-1/#comment-11818 Skippy Thu, 22 Jan 2009 18:42:07 +0000 http://blog.pharmtech.com/?p=716#comment-11818 What the numbers in this article do not show is the growth of biologics in the past 15 years and projections for the next 15 years. Those figures are available and would obviously educate this article much more so than the snippet of total sales from 2007. It's also interesting that since Merck's announcement, Pfizer, Lilly, and others have made similar "catch-up" announcements to keep pace with Novartis/Sandoz and Merck. What the numbers in this article do not show is the growth of biologics in the past 15 years and projections for the next 15 years. Those figures are available and would obviously educate this article much more so than the snippet of total sales from 2007. It’s also interesting that since Merck’s announcement, Pfizer, Lilly, and others have made similar “catch-up” announcements to keep pace with Novartis/Sandoz and Merck.

]]> http://blog.pharmtech.com/2008/12/19/merck-and-biosimilars-sound-business-or-just-small-molecule-blues/comment-page-1/#comment-11636 Kim Tue, 30 Dec 2008 22:54:07 +0000 http://blog.pharmtech.com/?p=716#comment-11636 It must cost way more than $10-50 million to take a biosimilar through the clinic. Merck will use 1.5 billion in the next 7 years to get 6 biosilimars on the market by 2017. So I doesn’t ad up It must cost way more than $10-50 million to take a biosimilar through the clinic. Merck will use 1.5 billion in the next 7 years to get 6 biosilimars on the market by 2017. So I doesn’t ad up

]]>